Can-Fite BioPharma Ltd. Registration statement for securities of certain foreign private issuers

Registration statement for securities of certain foreign private issuers

Cover
- Document and Entity Information
Financial Statements
Notes to Financial Statements
Accounting Policies
- Significant Accounting Policies (Policies)
Notes Tables
Notes Details

Short-Term Investment

Short-Term Investment	12 Months Ended
Dec. 31, 2018
Short-Term Investment [Abstract]
SHORT-TERM INVESTMENT	NOTE 6:- SHORT-TERM INVESTMENT The Company holds 356,803 shares of Wize Pharma Inc. as of December 31, 2018 and December 31, 2017 which as of such date represents 3.9% and 8.2% percent of Wize Pharma Inc’s outstanding shares, respectively. The shares are classified as financial asset as designated at fair value through profit or loss. As of December 31, 2017, the investment was classified under non-current assets.

Short-Term Investment

12 Months Ended

Dec. 31, 2018

Short-Term Investment [Abstract]

SHORT-TERM INVESTMENT

NOTE 6:- SHORT-TERM INVESTMENT

The Company holds 356,803 shares of Wize Pharma Inc. as of December 31, 2018 and December 31, 2017 which as of such date represents 3.9% and 8.2% percent of Wize Pharma Inc’s outstanding shares, respectively. The shares are classified as financial asset as designated at fair value through profit or loss. As of December 31, 2017, the investment was classified under non-current assets.